Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities... Show more
Acadia Healthcare Company, Inc. (ACHC) is a leading provider of behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities, residential treatment centers, and outpatient clinics, focusing on mental health and substance use disorders. Its core business model revolves around delivering specialized care through a network of over 250 facilities, emphasizing capacity expansion and operational efficiency. In the competitive behavioral health industry, Acadia holds a strong position due to its scale and focus on high-acuity patients, which has supported recent stock price resilience amid sector demand for mental health services.
Over the last 30 days, ACHC stock has climbed +10%, moving from approximately $23.39 to $25.82. The movement was volatile and trend-driven, with a steady uptrend through mid-April peaking near $28.57 before a pullback post-earnings.
In the past quarter, shares have advanced +92%, from around $13.44 to the current $25.82 level. This period featured sharp recoveries, high-volume spikes, and overall upward momentum, transitioning from range-bound lows in January to higher trading ranges in April.
The primary catalyst for ACHC's 30-day gain was the April 29, 2026, release of Q1 2026 earnings, which surprised on the upside for sales while revealing operating margin contraction to 1.3% from 5.5% in the prior-year quarter. Revenue beat expectations, supporting a pre-release rally that pushed shares above $28. However, the margin squeeze and cautious guidance triggered a subsequent drop, contributing to intraday volatility. Analyst reactions were mixed, with a Hold rating prevailing and price targets near $29, reflecting tempered optimism on cost pressures in healthcare delivery. Broader market sentiment toward healthcare stocks, amid steady demand for behavioral services, also bolstered the uptrend.
The quarter's +92% surge was propelled by February 2026 Q4 2025 results, reporting revenue of $821.5 million (up 6.1% YoY) and full-year revenue of $3.313 billion (up 5.0%), alongside announcements of capacity growth that drove a 23% single-day jump. Earlier recovery from January lows around $11.43 stemmed from high-volume rebounds, possibly tied to short covering and renewed investor confidence in Acadia's expansion plans. Industry tailwinds in behavioral health, including rising awareness of mental health needs, outweighed macroeconomic pressures like inflation on operational costs. Institutional accumulation and positive sector trends amplified the sustained uptrend.
Tickeron’s Trending AI Robots page showcases the top-performing AI trading bots from a library of hundreds that analyze and trade thousands of stock tickers across various strategies, timeframes, and performance metrics like win rate, profit factor, and drawdown. These curated bots, often focused on momentum, mean reversion, or pattern recognition, are selected based on recent real-time results and relevance to current market trends, helping traders identify high-potential automated strategies without manual screening. Explore the page to see live rankings and deploy bots suited to your trading style.
Investors should monitor upcoming Q2 2026 earnings for updates on revenue growth, margin recovery, and guidance amid cost inflation. Key industry trends, such as regulatory changes in behavioral healthcare reimbursement and demand for inpatient services, could sway sentiment. Macro factors like interest rates impacting facility financing and broader healthcare policy shifts warrant attention. Strategic developments, including new facility openings or partnerships, along with analyst revisions and institutional ownership changes, remain critical risks and catalysts for future price movement.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
ACHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 45 cases where ACHC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 03, 2026. You may want to consider a long position or call options on ACHC as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ACHC just turned positive on June 03, 2026. Looking at past instances where ACHC's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHC advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ACHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
ACHC moved below its 50-day moving average on June 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ACHC crossed bearishly below the 50-day moving average on May 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.150) is normal, around the industry mean (219.450). P/E Ratio (20.207) is within average values for comparable stocks, (119.374). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.336). ACHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.657) is also within normal values, averaging (2.450).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of a network of behavioral health centers
Industry HospitalNursingManagement